Official Title
Uppföljning av Patienter Som intensivvårdats för COVID-19
Brief Summary

The study will follow COVID-19 patients who required intensive care after 3-6 months andone year after discharge from the ICU with functional level as well as organ function toassess recovery after COVID-19. Blood and urine will be collected for biobanking.

Detailed Description

The study will follow COVID-19 patients who required intensive care at Uppsala University
Hospital and were included in the Uppsala COVID-19 biobank. The patients will be
contacted after three to six months for a first follow-up with assessment of functional
level in activities of daily life, psychiatric symptoms, neurological symptoms and
working capacity as well as specific organ functions. The organ functions will include
circulation, respiration, coagulation, immune function and kidney function. In addition,
blood and urine will be collected for biobanking.

Unknown status
COVID19
ARDS
AKI
Circulatory Failure
Coagulation Disorder
Inflammatory Response
Eligibility Criteria

Inclusion Criteria:

- PCR-verified Covid-19

- Treated in ICU

Exclusion Criteria:

- Pregnant of breastfeeding

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Sweden
Locations

Uppsala University Hospital
Uppsala, Sweden

Investigator: Michael Hultström, MD. PhD.
Contact: +46186110000
michael.hultstrom@mcb.uu.se

Contacts

Michael Hultström, MD. PhD.
+46186110000
michael.hultstrom@mcb.uu.se

Robert Frithiof, MD. PhD.
+46186110000
robert.frithiof@surgsci.uu.se

Uppsala University Hospital
NCT Number
Keywords
Corona Virus
Acute Kidney Injury
sars
Vasopressor
Respiratory failure
MeSH Terms
COVID-19
Hemostatic Disorders
Blood Coagulation Disorders
Shock